Great Point Partners, LLC reports a 5.83% position in 450,000 common shares of JATT III Acquisition Corp. The position is identified as passive because the securities were not acquired or held to change or influence control, while Great Point, Jeffrey Jay and Lillian Nordahl have reported voting and Investment powers.
Key Highlights
- JATT III Acquisition Corp’s reported ownership percentage is calculated against 7,725,000 shares outstanding.
- Biomedical Value Fund, L.P. holds 297,000 JATT III common shares of record.
- The filing says the securities were not obtained or retained to influence control.
Great Point Partners, LLC reports a 5.83% position in 450,000 common shares of JATT III Acquisition Corp (NASDAQ: JTTT). The filing identifies the position as passive and says the securities were not obtained or retained to alter or affect control. Great Point, Dr. Jeffrey R. Jay, M.D. And Ms. Lillian Nordahl are identified as reporting persons connected with the position.
450,000 Common Shares
The reported percentage uses 7,725,000 shares outstanding, based on information attributed to JATT III’s Form 424B prospectus. Biomedical Value Fund, L.P. holds 297,000 common shares of record, while Biomedical Offshore Value Fund, Ltd. holds 153,000 common shares of record. Great Point Partners serves as investment manager for both funds. Dr. Jay, as Great Point’s senior managing member, and Ms. Nordahl, as its managing director, have voting and investment power over the shares held by the funds. The filing limits any beneficial-ownership attribution for Great Point, Dr. Jay and Ms. Nordahl to applicable pecuniary interests.
Passive Intent Stated
The filing says the securities were not obtained or retained to change or influence JATT III’s control. It also addresses transactions intended to produce that result and states an exception for nomination-related activities. The passive designation applies to Great Point, Dr. Jay and Ms. Nordahl in the reported ownership structure. Their disclosed roles include investment management, voting power and investment power over the shares held by Biomedical Value Fund and Biomedical Offshore Value Fund.
Joint Filing Agreement
Great Point, Dr. Jay and Ms. Nordahl are parties to a joint filing agreement. The agreement provides for a joint statement and assigns each reporting person responsibility for the timely filing of the statement and any amendments. Each person remains responsible for the completeness and accuracy of information concerning that person, while the agreement limits responsibility for information concerning the other reporting persons unless an inaccuracy is known or reasonably believed.





Please wait processing your request...